ArticleObesity surgery2018
Metabolic Surgery Comparing Sleeve Gastrectomy with Jejunal Bypass and Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients After 3 Years.
Article in Obesity surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass.BMC surgery · 2020Pooled it
- Sleeve Gastrectomy With Proximal Jejunal Bypass: Balancing Simplicity and Efficacy in Metabolic and Bariatric Surgery.Journal of metabolic and bariatric surgery · 2026Review
- Case Report: Single-incision laparoscopic sleeve gastrectomy plus jejunojejunal bypass for the treatment of type 2 diabetes in patients with obesity: a case series and review.Frontiers in surgery · 2026Article
- Sleeve Plus Procedures: A Review of Technical Evolution Along a Schematic Diagram.Obesity surgery · 2025Review
- Distinguishing Sleeve Gastrectomy with Jejunal Bypass (SG-JB) from Sleeve Gastrectomy with Jejunoileal Bypass (SG-JIB): An Urgent Call for Terminological Clarity.Obesity surgery · 2025Article
- When Hashtags Shape Surgical Choices: Social Media Hype and Its Impact on Bariatric Surgery Preferences in Taiwan.Obesity surgery · 2025Article
- Analysis of the Efficacy of Different Obesity Surgeries in Patients with Metabolic Syndrome.Obesity surgery · 2025Article
- HbA1c Reductions Following Sleeve Gastrectomy Versus Sleeve Gastrectomy With Proximal Jejunal Bypass: Significant Differences in Diabetic Patients.Journal of metabolic and bariatric surgery · 2024Article
- Short-term outcomes of sleeve gastrectomy plus uncut jejunojejunal bypass (SG-uncut JJB) in patients with obesity: a preliminary prospective cohort study.Langenbeck's archives of surgery · 2023Article
- Is the Sleeve Gastrectomy Sufficient or Does it Require Additional Surgical Procedures?Journal of metabolic and bariatric surgery · 2021Review
- Comparative Effects of Three Kinds of Bariatric Surgery: A Randomized Case-Control Study in Obese Patients.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020Article
- Surgical Morbidity in the Elderly Bariatric Patient: Does Age Matter?Obesity surgery · 2019Article
- Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery.Obesity surgery · 2019Article
- Short-Term Outcomes of Sleeve Gastrectomy plus Jejunojejunal Bypass: a Retrospective Comparative Study with Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Chinese Patients with BMI ≥ 35 kg/mObesity surgery · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSleeve gastrectomy with jejunal bypass (SGJB) and Roux-en-Y gastric bypass (RYGB) has shown good results with respect to type 2 diabetes mellitus (T2D) remission in our institution. In this study, we compared the efficacy and safety of SGJB versus RYGB in terms of T2D remission up to 3 years postoperatively. MATERIALS AND
methodsA retrospective cohort study of two groups of patients with T2D who underwent SGJB or RYGB. All patients were matched by age, presurgical body mass index (BMI), glycated hemoglobin (HbA1c), and diabetes duration. Complete remission was defined as HbA1c of < 6%, fasting plasma glucose (FPG) of < 100 mg/dL, and no antidiabetic drugs.
resultsIn total, 57 and 55 patients in the SGJB and RYGB groups, respectively, met the inclusion criteria. The diabetes remission rate was similar between the SGJB and RYGB groups at 1 year postoperatively (69.2 vs. 64.7%) and 3 years postoperatively (56.1 vs. 58.8%). There were no significant differences in HbA1c or FPG at 1 or 3 years between the two groups. Additionally, weight loss and other metabolic parameters were similar between the groups. Clinical chemistry values were similar at 12 months except for hematocrit and calcium, which were significantly lower in the RYGB group. There were no differences in surgical complications.
conclusionsBoth procedures showed similar results in terms of T2D remission and other metabolic markers at 3 years. Hematocrit and calcium were significantly higher in the SGJB than RYGB group. SGJB is as effective and safe as RYGB in obese patients with T2D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.